Stephen Hull is Principal and Founder of Hull Associates LLC, a specialized global reimbursement strategy firm focused on pharmaceutical, medical device, diagnostic and biotech technologies.
With 40 seasoned partners worldwide, Hull Associates LLC develops and executes strategies for reimbursement and product launches in major global markets, including the Americas, the Asia Pacific, Northern and Eastern Europe, the Middle East, and Western Europe.
Stephen Hull has more than 25 years of experience in health policy and medical product strategy, for pharmaceuticals, medical devices, diagnostics and biotech products.
Prior to forming Hull Associates, he served as Senior Vice President for Global Reimbursement at AdvaMed in Washington, D.C., the leading U.S.-based medical technology trade association. Internationally, he designed and launched numerous joint advocacy campaigns, with a primary focus on reimbursement issues, working with sister associations in the major overseas markets.
Before his trade association work, Stephen was a Principal at Covance Health Economics and Outcomes Services, where he executed numerous private and public payor reimbursement and market strategies.
Stephen has also served as chairman of the Medical Devices Council for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Stephen has an advanced degree in health policy from the Johns Hopkins Bloomberg School of Public Health, and a bachelor’s degree in international relations and French from Colgate University.